EU Kovid Vaccine Rollout ‘Slow’; Germany, France tighten restrictions


During a vaccination campaign at a nursing home in Athens, a nurse produces a syringe of the Kovid-19 vaccine.

Lucy Gowiyami | AFP | Getty Images

The European Union has been criticized for the speed of deployment of Kovid vaccines, as its two largest economies extend their coronovirus ban due to worrisome numbers.

Over the past few days, many European officials have voiced their concerns about Bloc’s vaccination plans and have asked the European Commission for an EU executive hand to explain why it has not bought more jobs.

According to the European Center for Disease Prevention and Control, there have been more than 17 million cases of coronavirus in the region to date (including the UK).

“It is difficult to explain that a very good vaccine has been developed in Germany, but is quickly vaccinated elsewhere,” said Marcus Sauder, leader of the Bavaria region of Germany, quoting Politico. German company BioNTech together with Pfizer has developed one of the leading Kovid vaccines.

The European Union began its vaccination program in late December following the approval of the Pfizer / Bioentech jab. Despite being developed in Germany, however, the jab was well cleared in Britain and the United States by the European authorities before greening.

BioNTech’s chief executive, Uroor ğ Hin, also told the German press over the weekend that “the process in Europe was certainly not as fast and direct as in other countries.”

Meanwhile, Britain has approved two other vaccines, but the European Medicines Agency has not yet decided on AstraZeneca’s or Modern’s offerings.

In addition to timely concerns, there are also questions about whether enough vaccines have been purchased by the European Union.

“The (European) Commission should rise to the occasion. To this end, how will the EU make up for the lack of supplements purchased in the EU?” Luis Garricano, a European MP, wrote a letter to Commission President Ursula von der Leyen over the weekend.

The European Commission has signed six contracts with vaccine makers on behalf of European countries. Each EU nation will receive vaccines at the same time and distribution will be on a per capita basis.

Between these contracts, the EU agreed to purchase 200 million doses of the Pfizer / BioNTech vaccine, with the option to purchase an additional 100 million doses. The commission also agreed to purchase 300 million vaccine doses from AstraZeneca, with an option to purchase 100 million more. Its contract with Modern is agreed to purchase 80 million doses, with an option to purchase up to 80 million more.

According to the region’s statistical office, more than 447 million citizens live in 27 EU countries.

“Israel, a country with just 1 / 50th of the population of the European Union, has more vaccination of its citizens than all member states of the United Nations. Madam President, how is this possible?” Garrican asked Len Vaughan in his letter.

A spokesperson for the European Commission said on Monday that the institution was “too focused on ensuring that our strategy is implemented, that’s fine.”

“The Commission has long ago understood that both the vaccine acquisition and the vaccination process will be major efforts for the European Union,” the spokesperson told reporters.

France, one of the most vaccinated countries in the European Union, announced last week that it was advancing its vaccination process. The country is also modifying curfew hours in the most affected areas in an effort to stop the spread of the virus.

Meanwhile, Germany, where there has been a national lockout since late November, is due to extend this emergency measure by the end of the month.

Visitors queue outside a Kovid-19 vaccination site at the Berlin Arena in Berlin, Germany.

Bloomberg Bloomberg Getty Images

.

Leave a Reply

Your email address will not be published.